STANDARD BIOTOOLS INC. (LAB)

↓ Download CSV

CIK 0001162194 · Nasdaq · Laboratory Analytical Instruments

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, STANDARD BIOTOOLS INC. reported revenue of $85.33M, down 6.2% from the prior year. The company ran a net loss, with a net margin of -87.8% and a gross margin of 49.9%. It held $567.75M in total assets against $143.46M in total liabilities.

Key ratios (FY2025)

49.9%
Gross margin
-129.2%
Operating margin
-87.8%
Net margin
-17.7%
Return on equity
-6.2%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$85.33M$91.01M$106.34M$97.95M$130.58M$138.14M$117.24M$112.96M$101.94M$104.45M
Cost of Revenue$42.79M$46.12M$55.89M$60.90M$52.96M$51.31M$49.95M$46.01M
Gross Profit$42.54M$44.88M$50.45M$37.05M$64.28M$61.65M$51.98M$58.44M
Operating Income-$110.25M-$127.48M-$76.60M-$116.20M-$67.46M-$51.04M-$51.84M-$48.16M-$58.36M-$73.19M
Net Income-$74.90M-$138.88M-$74.66M-$190.10M-$59.24M-$53.02M-$64.79M-$59.01M-$60.53M-$75.98M
EPS (Diluted)$-0.20$-0.52$-0.94$-2.43$-0.78$-0.74$-0.97
Total Assets$567.75M$612.35M$323.07M$390.31M$275.21M$324.76M$264.81M$303.65M$287.35M$306.39M
Total Liabilities$143.46M$140.62M$159.87M$160.52M$180.62M$185.71M$111.20M$231.53M$256.42M$253.16M
Shareholders' Equity$424.29M$471.72M-$148.05M-$81.47M$94.60M$139.05M$153.61M$72.12M$30.93M$53.23M
Cash & Equivalents$120.86M$166.73M$51.70M$81.31M$28.45M$68.52M$21.66M$95.40M$58.06M$35.05M
Operating Cash Flow-$74.34M-$143.45M-$43.29M-$89.37M-$44.06M-$15.42M-$35.21M-$25.20M-$24.10M-$39.14M
Capital Expenditures$8.30M$8.36M$2.83M$3.83M$13.26M$12.72M$2.53M$372.0K$1.57M$5.07M
Shares Outstanding386.38M377.53M80.23M79.48M76.92M74.54M69.96M49.34M38.79M29.21M